Evidence map›Paper›PMID 37762912›Full record

ArticleJournal of clinical medicine2023

Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity: A Euro-DEN Plus Study.

Roberta Noseda, Matteo Franchi, Alberto Pagnamenta, Laura Müller, Alison M Dines, Isabelle Giraudon, Fridtjof Heyerdahl, Florian Eyer, Knut Erik Hovda, Matthias E Liechti and 7 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Roberta NosedaDivision of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.ORCID 0000-0002-4946-7926
Matteo FranchiUnit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, 20126 Milan, Italy.ORCID 0000-0001-9620-8057
Alberto PagnamentaClinical Trial Unit, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
Laura MüllerDivision of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
Alison M DinesClinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London SE1 7EH, UK.
Isabelle GiraudonEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 1249-289 Lisbon, Portugal.
Fridtjof HeyerdahlPrehospital Division, Oslo University Hospital, 0424 Oslo, Norway.ORCID 0000-0001-9602-4370
Florian EyerDepartment of Clinical Toxicology, Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0002-4753-2747
Knut Erik HovdaThe Norwegian CBRNE Centre of Medicine, Oslo University Hospital, 0450 Oslo, Norway.ORCID 0000-0001-6341-8699
Matthias E LiechtiClinical Pharmacology and Toxicology, University Hospital and University of Basel, 4056 Basel, Switzerland.ORCID 0000-0002-1765-9659
Òscar MiróEmergency Department, Hospital Clínic, University of Barcelona, 08036 Catalonia, Spain.
Odd Martin VallersnesDepartment of General Practice, University of Oslo, 0318 Oslo, Norway.ORCID 0000-0003-1213-392X
Christopher YatesEmergency Department and Clinical Toxicology Unit, Hospital Universitario Son Espases, 07120 Mallorca, Spain.
Paul I DarganClinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London SE1 7EH, UK.
David M WoodClinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London SE1 7EH, UK.
Alessandro CeschiDivision of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.ORCID 0000-0002-4308-0405
Euro-DEN Research Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to characterize patients admitted to critical care following Emergency Department (ED) presentation with acute recreational drug toxicity and to identify determinants of admission to critical care. A retrospective multicenter matched case-control study was conducted by the European Drug Emergency Network Plus (Euro-DEN Plus) over the period 2014-2021. The cases were ED presentations with acute recreational drug toxicity admitted to critical care, the controls consisted of ED presentations with acute recreational drug toxicity medically discharged directly from the ED. The potential determinants of admission to critical care were assessed through multivariable conditional stepwise logistic regression analysis and multiple imputation was used to account for the missing data. From 2014 to 2021, 3448 Euro-DEN Plus presentations involved patients admitted to critical care (76.9% males; mean age 33.2 years; SD 10.9 years). Patient age ≥35 years (as compared to ≤18 years) was a determinant of admission to critical care following acute recreational drug toxicity (adjusted odds ratio, aOR, 1.51, 95% confidence interval, CI, 1.15-1.99), along with polydrug use (aOR 1.39, 95% CI 1.22-1.59), ethanol co-ingestion (aOR 1.44, 95% CI 1.26-1.64), and the use of gamma-hydroxybutyrate/gamma-butyrolactone (GHB/GBL, aOR 3.08, 95% CI 2.66-3.57). Conversely, lower odds of admission to critical care were associated with the use of cocaine (aOR 0.85, 95% CI 0.74-0.99), cannabis (aOR 0.44, 95% CI 0.37-0.52), heroin (aOR 0.80, 95% CI 0.69-0.93), and amphetamine (aOR 0.65, 95% CI 0.54-0.78), as was the arrival to the ED during the night (8 p.m.-8 a.m., aOR 0.88, 95% CI 0.79-0.98). These findings, which deserve confirmation and further investigation, could contribute to a more complete understanding of the decision-making process underlying the admission to critical care of patients with acute recreational drug toxicity.

Indexed as

determinants of critical care admissionEmergency Department presentationEuro-DEN Plusrecreational drug usetoxicity

Identifiers

PMID37762912
PMCPMC10532086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.